{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:20:01Z","timestamp":1778926801902,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prescription patterns of antipsychotic drugs (APDs) are typically sourced from country-specific data. In this study, a digital pharmacoepidemiological approach was used to investigate APD preferences globally. Publicly available data on worldwide web search intensities in Google for 19 typical and 22 atypical APDs were temporally and spatially normalized and correlated with reported prescription data. The results demonstrated an increasing global preference for atypical over typical APDs since 2007, with quetiapine, olanzapine, risperidone, and aripiprazole showing the largest search intensities in 2020. Cross-sectional analysis of 122 countries in 2020 showed pronounced differences in atypical\/typical APD preferences that correlated with gross domestic product per capita. In conclusion, the investigation provides temporal and spatial assessments of global APD preferences and shows a trend towards atypical APDs, although with a relative preference for typical APDs in low-income countries. Similar data-sourcing methodologies allow for prospective studies of other prescription drugs.<\/jats:p>","DOI":"10.1038\/s41598-021-92204-0","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T10:05:05Z","timestamp":1624442705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Worldwide antipsychotic drug search intensities: pharmacoepidemological estimations based on Google Trends data"],"prefix":"10.1038","volume":"11","author":[{"given":"Richard","family":"\u00c5gren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"92204_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bdi.12423","volume":"18","author":"AJ Ferrari","year":"2016","unstructured":"Ferrari, A. J. et al. The prevalence and burden of bipolar disorder: findings from the global burden of disease study 2013. Bipolar Disord. 18, 440\u2013450. https:\/\/doi.org\/10.1111\/bdi.12423 (2016).","journal-title":"Bipolar Disord."},{"key":"92204_CR2","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/schbul\/sby058","volume":"44","author":"FJ Charlson","year":"2018","unstructured":"Charlson, F. J. et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr. Bull. 44, 1195\u20131203. https:\/\/doi.org\/10.1093\/schbul\/sby058 (2018).","journal-title":"Schizophr. Bull."},{"key":"92204_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/schbul\/sbu164","volume":"41","author":"M Torniainen","year":"2015","unstructured":"Torniainen, M. et al. Antipsychotic treatment and mortality in schizophrenia. Schizophr. Bull. 41, 656\u2013663. https:\/\/doi.org\/10.1093\/schbul\/sbu164 (2015).","journal-title":"Schizophr. Bull."},{"key":"92204_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1755-5949.2010.00222.x","volume":"17","author":"M Nord","year":"2011","unstructured":"Nord, M. & Farde, L. Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci. Ther. 17, 97\u2013103. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00222.x (2011).","journal-title":"CNS Neurosci. Ther."},{"key":"92204_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth, B. L., Sheffler, D. J. & Kroeze, W. K. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov. 3, 353\u2013359. https:\/\/doi.org\/10.1038\/nrd1346 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"92204_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn, M. et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 394, 939\u2013951. https:\/\/doi.org\/10.1016\/S0140-6736(19)31135-3 (2019).","journal-title":"Lancet"},{"key":"92204_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.mp.4002066","volume":"13","author":"HA Nasrallah","year":"2008","unstructured":"Nasrallah, H. A. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Mol. Psychiatry 13, 27\u201335. https:\/\/doi.org\/10.1038\/sj.mp.4002066 (2008).","journal-title":"Mol. Psychiatry"},{"key":"92204_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1192\/bjp.bp.106.028654","volume":"191","author":"LM Davies","year":"2007","unstructured":"Davies, L. M. et al. Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy. Br. J. Psychiatry 191, 14\u201322. https:\/\/doi.org\/10.1192\/bjp.bp.106.028654 (2007).","journal-title":"Br. J. Psychiatry"},{"key":"92204_CR9","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1176\/ajp.2006.163.12.2080","volume":"163","author":"RA Rosenheck","year":"2006","unstructured":"Rosenheck, R. A. et al. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Am. J. Psychiatry 163, 2080\u20132089. https:\/\/doi.org\/10.1176\/ajp.2006.163.12.2080 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"92204_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1517\/14656566.7.13.1749","volume":"7","author":"P Hanrahan","year":"2006","unstructured":"Hanrahan, P., Luchins, D. J., Fabian, R. & Tolley, G. Cost-effectiveness of atypical antipsychotic medications versus conventional medication. Expert Opin. Pharmacother. 7, 1749\u20131758. https:\/\/doi.org\/10.1517\/14656566.7.13.1749 (2006).","journal-title":"Expert Opin. Pharmacother."},{"key":"92204_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht, S. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382, 951\u2013962. https:\/\/doi.org\/10.1016\/S0140-6736(13)60733-3 (2013).","journal-title":"Lancet"},{"key":"92204_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/wps.20579","volume":"17","author":"M Carbon","year":"2018","unstructured":"Carbon, M., Kane, J. M., Leucht, S. & Correll, C. U. Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis. World Psychiatry 17, 330\u2013340. https:\/\/doi.org\/10.1002\/wps.20579 (2018).","journal-title":"World Psychiatry"},{"key":"92204_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40801-016-0084-3","volume":"3","author":"P Zagozdzon","year":"2016","unstructured":"Zagozdzon, P., Goyke, B. & Wrotkowska, M. Mortality rates in users of typical and atypical antipsychotics: a database study in Poland. Drugs Real World Outcomes 3, 345\u2013351. https:\/\/doi.org\/10.1007\/s40801-016-0084-3 (2016).","journal-title":"Drugs Real World Outcomes"},{"key":"92204_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s2215-0366(16)00085-7","volume":"3","author":"G Grunder","year":"2016","unstructured":"Grunder, G. et al. Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study. Lancet Psychiatry 3, 717\u2013729. https:\/\/doi.org\/10.1016\/s2215-0366(16)00085-7 (2016).","journal-title":"Lancet Psychiatry"},{"key":"92204_CR15","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","volume":"27","author":"O Halfdanarson","year":"2017","unstructured":"Halfdanarson, O. et al. International trends in antipsychotic use: a study in 16 countries, 2005\u20132014. Eur. Neuropsychopharmacol. 27, 1064\u20131076. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.07.001 (2017).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"92204_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/acps.12742","volume":"136","author":"CJ Bachmann","year":"2017","unstructured":"Bachmann, C. J. et al. International trends in clozapine use: a study in 17 countries. Acta Psychiatr. Scand. 136, 37\u201351. https:\/\/doi.org\/10.1111\/acps.12742 (2017).","journal-title":"Acta Psychiatr. Scand."},{"key":"92204_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1440-1819.2004.01194.x","volume":"58","author":"M-Y Chong","year":"2004","unstructured":"Chong, M.-Y. et al. Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry Clin. Neurosci. 58, 61\u201367. https:\/\/doi.org\/10.1111\/j.1440-1819.2004.01194.x (2004).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"92204_CR18","doi-asserted-by":"publisher","first-page":"112271","DOI":"10.1016\/j.psychres.2019.02.056","volume":"287","author":"S-W Xu","year":"2020","unstructured":"Xu, S.-W. et al. Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016). Psychiatry Res. 287, 112271. https:\/\/doi.org\/10.1016\/j.psychres.2019.02.056 (2020).","journal-title":"Psychiatry Res."},{"key":"92204_CR19","doi-asserted-by":"publisher","first-page":"14473","DOI":"10.1073\/pnas.1515373112","volume":"112","author":"S Yang","year":"2015","unstructured":"Yang, S., Santillana, M. & Kou, S. C. Accurate estimation of influenza epidemics using Google search data via ARGO. Proc. Natl. Acad. Sci. 112, 14473. https:\/\/doi.org\/10.1073\/pnas.1515373112 (2015).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"92204_CR20","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1073\/pnas.1523941113","volume":"113","author":"KM Bakker","year":"2016","unstructured":"Bakker, K. M., Martinez-Bakker, M. E., Helm, B. & Stevenson, T. J. Digital epidemiology reveals global childhood disease seasonality and the effects of immunization. Proc. Natl. Acad. Sci. 113, 6689. https:\/\/doi.org\/10.1073\/pnas.1523941113 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"92204_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.21037\/atm.2017.06.65","volume":"5","author":"G Lippi","year":"2017","unstructured":"Lippi, G., Mattiuzzi, C., Cervellin, G. & Favaloro, E. J. Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends. Ann. Transl. Med. 5, 322. https:\/\/doi.org\/10.21037\/atm.2017.06.65 (2017).","journal-title":"Ann. Transl. Med."},{"key":"92204_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","volume":"18","author":"JA Lieberman","year":"2004","unstructured":"Lieberman, J. A. Dopamine partial agonists: a new class of antipsychotic. CNS Drugs 18, 251\u2013267. https:\/\/doi.org\/10.2165\/00023210-200418040-00005 (2004).","journal-title":"CNS Drugs"},{"key":"92204_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/wics.147","volume":"3","author":"H Wickham","year":"2011","unstructured":"Wickham, H. ggplot2. Wiley Interdiscip. Rev. Comput. Stat. 3, 180\u2013185 (2011).","journal-title":"Wiley Interdiscip. Rev. Comput. Stat."},{"key":"92204_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1017\/S2045796015000694","volume":"25","author":"YT Xiang","year":"2016","unstructured":"Xiang, Y. T., Ungvari, G. S., Correll, C. U., Chiu, H. F. K. & Shinfuku, N. Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia. Epidemiol. Psychiatr. Sci. 25, 9\u201317. https:\/\/doi.org\/10.1017\/S2045796015000694 (2016).","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"92204_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ajp.2019.08.010","volume":"45","author":"M Dong","year":"2019","unstructured":"Dong, M. et al. Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: findings of the 2016 research on Asian psychotropic prescription patterns (REAP) survey. Asian J. Psychiatry 45, 74\u201380. https:\/\/doi.org\/10.1016\/j.ajp.2019.08.010 (2019).","journal-title":"Asian J. Psychiatry"},{"key":"92204_CR26","volume-title":"WHO Model List of Essential Medicines, 20th List (March 2017, Amended August 2017)","author":"World Health O","year":"2017","unstructured":"World Health O. WHO Model List of Essential Medicines, 20th List (March 2017, Amended August 2017) (World Health Organization, 2017)."},{"key":"92204_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/ndt.s4903","volume":"6","author":"RK Al-Jurdi","year":"2010","unstructured":"Al-Jurdi, R. K., Dixit, L. A. & Sajatovic, M. Role of extended release quetiapine in the management of bipolar disorders. Neuropsychiatr. Dis. Treat. 6, 29\u201335. https:\/\/doi.org\/10.2147\/ndt.s4903 (2010).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"92204_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-3956(01)00020-6","volume":"35","author":"ID Glick","year":"2001","unstructured":"Glick, I. D., Murray, S. R., Vasudevan, P., Marder, S. R. & Hu, R. J. Treatment with atypical antipsychotics: new indications and new populations. J. Psychiatr. Res. 35, 187\u2013191. https:\/\/doi.org\/10.1016\/S0022-3956(01)00020-6 (2001).","journal-title":"J. Psychiatr. Res."},{"key":"92204_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1176\/appi.ps.201500482","volume":"68","author":"PL O\u2019Brien","year":"2017","unstructured":"O\u2019Brien, P. L., Cummings, N. & Mark, T. L. Off-label prescribing of psychotropic medication, 2005\u20132013: an examination of potential influences. Psychiatr. Serv. 68, 549\u2013558. https:\/\/doi.org\/10.1176\/appi.ps.201500482 (2017).","journal-title":"Psychiatr. Serv."},{"key":"92204_CR30","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","volume":"21","author":"L Carton","year":"2015","unstructured":"Carton, L. et al. Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends. Curr. Pharm. Des. 21, 3280\u20133297. https:\/\/doi.org\/10.2174\/1381612821666150619092903 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"92204_CR31","doi-asserted-by":"publisher","first-page":"27942","DOI":"10.3402\/gha.v8.27942","volume":"8","author":"BH Wagenaar","year":"2015","unstructured":"Wagenaar, B. H. et al. The availability of essential medicines for mental healthcare in Sofala, Mozambique. Glob. Health Action 8, 27942\u201327942. https:\/\/doi.org\/10.3402\/gha.v8.27942 (2015).","journal-title":"Glob. Health Action"},{"key":"92204_CR32","first-page":"669","volume":"36","author":"CL Ventola","year":"2011","unstructured":"Ventola, C. L. Direct-to-consumer pharmaceutical advertising: Therapeutic or toxic?. P T Peer Rev J Formul. Manag. 36, 669\u2013684 (2011).","journal-title":"P T Peer Rev J Formul. Manag."},{"key":"92204_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jacbts.2016.06.003","volume":"1","author":"GA Van Norman","year":"2016","unstructured":"Van Norman, G. A. Drugs and devices: comparison of European and U.S. approval processes. JACC Basic Transl. Sci. 1, 399\u2013412. https:\/\/doi.org\/10.1016\/j.jacbts.2016.06.003 (2016).","journal-title":"JACC Basic Transl. Sci."},{"key":"92204_CR34","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1038\/srep02713","volume":"3","author":"L Kristoufek","year":"2013","unstructured":"Kristoufek, L. Can Google Trends search queries contribute to risk diversification?. Sci. Rep. 3, 2713. https:\/\/doi.org\/10.1038\/srep02713 (2013).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92204-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92204-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92204-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T10:05:42Z","timestamp":1670061942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92204-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92204"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92204-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13136"}}